does semaglutide reduce inflammation GLP-1 drugs calm beyond diabetes and weight loss Semaglutide works with your biology

Rather, it promotes the development of broadly inhibitory antibodies, the researchers report

Aim To examine the association between self-medication for vitamin B12 deficiency and patient-reported safety in primary care

K., Karadas, B., & Kaplan, Y

Recently, Pfizer also successfully secured the ownership of GLP-1 biotechnology company Metsera after a surprise bidding conflict, adding Metseras injectable asset, MET-097i (which is in Phase 2b testing and has the potential for once-a-month dosing), to its portfolio

Reporting summary Further information on research design is available in the Nature Portfolio Reporting Summary linked to this article